Alternating tangential flow cell retention for upstream intensification, 1 L to 5,000 L.
The XCell® ATF System uses award-winning alternating tangential flow technology, driven by a diaphragm pump moving within a pump head connected to a hollow-fiber filter housing on the bioreactor. This intensification delivers up to 10× higher viable cell density versus traditional fed-batch, reduces bioreactor time by about 50%, and enables up to 20-fold yield increases for certain therapeutics.
The complete solution spans single-use and stainless-steel device formats from lab scale (0.5 L) to commercial scale (5,000 L), integrated Lab, LS and C410 controllers, touchscreen interfaces, flow-sensor process monitoring and full software integration. It simplifies tech transfer from process development to cGMP manufacturing across perfusion, seed train intensification, fed-batch enhancement and media exchange for gene therapy, monoclonal antibody and vaccine production.
Video: Watch on YouTube
- Biopharma
- Pharmaceutical